{"id":3088,"date":"2016-02-16T07:30:00","date_gmt":"2016-02-16T07:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/perfadex-och-steen-solution-godkanda-i-ryssland\/"},"modified":"2016-02-16T07:30:00","modified_gmt":"2016-02-16T07:30:00","slug":"perfadex-och-steen-solution-godkanda-i-ryssland","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/perfadex-och-steen-solution-godkanda-i-ryssland\/","title":{"rendered":"PERFADEX\u00ae och STEEN Solution\u2122 godk\u00e4nda i Ryssland"},"content":{"rendered":"
XVIVO Perfusion har erh\u00e5llit godk\u00e4nnande i Ryssland f\u00f6r marknadsf\u00f6ring och klinisk anv\u00e4ndning av PERFADEX\u00ae<\/sup> och STEEN Solution\u2122.<\/strong><\/div>\n<\/p>\n

Rysslands Federal Service for Supervision on Health Care har godk\u00e4nt PERFADEX\u00ae<\/sup> och STEEN Solution\u2122 f\u00f6r lungtransplantation, vilket m\u00f6jligg\u00f6r f\u00f6rs\u00e4ljning till klinisk anv\u00e4ndning av PERFADEX\u00ae<\/sup> och STEEN Solution\u2122 i Ryssland. <\/span><\/p>\n<\/p>\n

Ryssland \u00e4r idag inte en stor marknad, men det finns ett stort behov av att fler lungtransplantationer utf\u00f6rs i regionen. I och med registreringen m\u00f6jligg\u00f6rs det att klinikerna i Ryssland f\u00e5r tillg\u00e5ng till PERFADEX\u00ae<\/sup> som \u00e4r anpassat f\u00f6r lungpreservation samt m\u00f6jligheten att utv\u00e4rdera lungornas kvalitet med STEEN Solution\u2122 genom Ex Vivo Lung Perfusion (EVLP). <\/span><\/p>\n<\/p>\n

\u201dRegisteringen av PERFADEX\u00ae<\/sup> och STEEN Solution\u2122 i Ryssland \u00f6kar tillg\u00e4ngligheten av lungtransplantationsprodukter i denna region och \u00e4r ett steg i r\u00e4tt riktning mot v\u00e5r vision \u201dIngen skall beh\u00f6va d\u00f6 i v\u00e4ntan p\u00e5 ett nytt organ\u201d. Det ligger ocks\u00e5 i linje med v\u00e5r l\u00e5ngsiktiga satsning p\u00e5 de framtida tillv\u00e4xtmarknaderna.\u201d s\u00e4ger VD Magnus Nilsson, XVIVO Perfusion.<\/span><\/p>\n<\/p>\n

G\u00f6teborg 16 februari 2016
XVIVO Perfusion AB (publ)<\/span><\/p>\n

\n

F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/p>\n

Christoffer Rosenblad, CFO, tel: +1\u00a0720\u00a0616 2101, e-post: christoffer.rosenblad@xvivoperfusion.com
<\/a>Magnus Nilsson, VD, tel: 031-788 21 50, e-post: magnus.nilsson@xvivoperfusion.com<\/span><\/p>\n

F\u00f6r ytterligare information om XVIVO Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, www.xvivoperfusion.com<\/a><\/span><\/p>\n

Informationen l\u00e4mnades f\u00f6r publicering den 16 februari 2016 kl. 08:30.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

XVIVO Perfusion har erh\u00e5llit godk\u00e4nnande i Ryssland f\u00f6r marknadsf\u00f6ring och klinisk anv\u00e4ndning av PERFADEX\u00ae och STEEN Solution\u2122. Rysslands Federal Service…<\/p>\n","protected":false},"template":"","class_list":["post-3088","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"\nPERFADEX\u00ae och STEEN Solution\u2122 godk\u00e4nda i Ryssland - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/perfadex-och-steen-solution-godkanda-i-ryssland\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PERFADEX\u00ae och STEEN Solution\u2122 godk\u00e4nda i Ryssland - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO Perfusion har erh\u00e5llit godk\u00e4nnande i Ryssland f\u00f6r marknadsf\u00f6ring och klinisk anv\u00e4ndning av PERFADEX\u00ae och STEEN Solution\u2122. Rysslands Federal Service...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/perfadex-och-steen-solution-godkanda-i-ryssland\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/perfadex-och-steen-solution-godkanda-i-ryssland\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/perfadex-och-steen-solution-godkanda-i-ryssland\\\/\",\"name\":\"PERFADEX\u00ae och STEEN Solution\u2122 godk\u00e4nda i Ryssland - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2016-02-16T07:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/perfadex-och-steen-solution-godkanda-i-ryssland\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/perfadex-och-steen-solution-godkanda-i-ryssland\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/perfadex-och-steen-solution-godkanda-i-ryssland\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PERFADEX\u00ae och STEEN Solution\u2122 godk\u00e4nda i Ryssland\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PERFADEX\u00ae och STEEN Solution\u2122 godk\u00e4nda i Ryssland - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/perfadex-och-steen-solution-godkanda-i-ryssland\/","og_locale":"en_US","og_type":"article","og_title":"PERFADEX\u00ae och STEEN Solution\u2122 godk\u00e4nda i Ryssland - XVIVO","og_description":"XVIVO Perfusion har erh\u00e5llit godk\u00e4nnande i Ryssland f\u00f6r marknadsf\u00f6ring och klinisk anv\u00e4ndning av PERFADEX\u00ae och STEEN Solution\u2122. Rysslands Federal Service...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/perfadex-och-steen-solution-godkanda-i-ryssland\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/perfadex-och-steen-solution-godkanda-i-ryssland\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/perfadex-och-steen-solution-godkanda-i-ryssland\/","name":"PERFADEX\u00ae och STEEN Solution\u2122 godk\u00e4nda i Ryssland - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2016-02-16T07:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/perfadex-och-steen-solution-godkanda-i-ryssland\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/perfadex-och-steen-solution-godkanda-i-ryssland\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/perfadex-och-steen-solution-godkanda-i-ryssland\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"PERFADEX\u00ae och STEEN Solution\u2122 godk\u00e4nda i Ryssland"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}